Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells

Bone Marrow Transplantation

Volumn 49, Issue 2, 2014, Pages 212-218

  Kwon, M ^a   Martinez Laperche C ^a   Balsalobre, P ^a   Serrano, D ^a   Anguita, J ^a   Gayoso, J ^a   Diez Martin J L ^a   Buno I ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Chimerism; Cord blood transplantation; Graft failure; Haploidentical donor

Indexed keywords

ADULT; CHIMERISM; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84893716118     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.177     Document Type: Article

References (30)

1. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
2. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang M-J, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653-660.
3. Sanz J, Boluda JCH, Mart?́n C, González M, Ferrá C, Serrano D et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone marrow transplantation 2012; 47: 1287-1293.
4. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang M-J, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New Engl J Med 2004; 351: 2265-2275.
5. Fernández MN, Regidor C, Cabrera R, Garc?́a-Marco JA, Foré s R, Sanjuán I et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34\+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535-544.
6. Bautista G, Cabrera JR, Regidor C, Foré s R, Garc?́a-Marco JA, Ojeda E et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplant 2009; 43: 365-373.
7. Kwon M, Balsalobre P, Serrano D, Pérez Corral A, Buño I, Anguita J et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol. Blood Marrow Transplant 2012; 19: 143-149.
8. Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood 2011; 118: 6438-6445.
9. Mattsson J, Ringdén O, Storb R.. Graft Failure after Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant 2008; 14(Supple 1): 165-170.
10. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
11. Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2009; 113: 1631-1638.
12. Rondón G, Saliba RM, Khouri I, Giralt S, Chan K, Jabbour E et al. Long-term followup of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol. Blood Marrow Transplant 2008; 14: 859-866.
13. Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br. J. Haematol 2000; 111: 292-302.
14. Waki F, Masuoka K, Fukuda T, Kanda Y, Nakamae M, Yakushijin K et al. Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. Biol. Blood Marrow Transplant 2011; 17: 841-851.
15. Fuji S, Nakamura F, Hatanaka K, Taniguchi S, Sato M, Mori S-I et al. Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation [Internet]. 2012 Mar 16 [cited 2012 Jun 19]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/22430086.
16. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
17. Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010; 116: 2839-2846.
18. Page KM, Zhang L, Mendizabal A, Wease S, Carter S, Gentry T et al. Total colonyforming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol. Blood Marrow Transplant 2011; 17: 1362-1374.
19. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2060-2069.
20. Cimino G, Rapanotti MC, Elia L, Iori AP, Guglielmi C, Screnci M et al. A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. Br. J. Haematol 1999; 104: 770-777.
21. Chan KW, Grimley MS, Taylor C, Wall DA.. Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant 2008; 42: 35-41.
22. Moscardó F, Sanz J, Senent L, Cantero S, de la Rubia J, Montesinos P et al. Impact of hematopoietic chimerism at day \+14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies. Haematologica 2009; 94: 827-832.
23. Breuer S, Preuner S, Fritsch G, Daxberger H, Koenig M, Poetschger U et al. Early recipient chimerism testing in the T-and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia 2012; 26: 509-519.
24. Newell LF, Milano F, Nicoud IB, Pereira S, Gooley TA, Heimfeld S et al. Early CD3 Peripheral Blood Chimerism Predicts the Long-Term Engrafting Unit Following Myeloablative Double-Cord Blood Transplantation. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation [Internet]. 2012 Feb 8 [cited 2012 Jun 20]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/22326302.
25. Buño I, Anta B, Moreno-López E, Balsalobre P, Balas A, Garc?́a-Sánchez F et al. Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation. Leuk. Lymphoma 2003; 44: 659-667.
26. Buño I, Nava P, Simón A, González-Rivera M, Jiménez JL, Balsalobre P et al. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica 2005; 90: 1373-1379.
27. D?́ez-Mart?́n JL, Gómez-Pineda A, Serrano D, Carrión R, Balsalobre P, Buño I. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect. Bone Marrow Transplant 2004; 33: 1037-1041.
28. Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004; 33: 815-821.
29. Ho VT, Soiffer RJ.. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192-3204.
30. Avery S, Shi W, Lubin M, Gonzales AM, Heller G, Castro-Malaspina H et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011; 117: 3277-3285, quiz 3478.